|
Resurrecting the Environmental Movement |
Sunday, May 26, 2013 |
9:00 AM–9:50 AM |
Main Auditorium (Convention Center) |
Area: CSE; Domain: Service Delivery |
CE Instructor: Mark P. Alavosius, Ph.D. |
Chair: Mark P. Alavosius (University of Nevada, Reno) |
PETER KAREIVA (The Nature Conservancy) |
Dr. Peter Kareiva is the chief scientist and vice president of The Nature Conservancy, where he is responsible for maintaining the quality of more than 600 staff engaged in conservation science in more than 30 countries around the world. Kareiva studied political science and zoology at the Duke University for his bachelor's degree and ecology and applied mathematics at Cornell University for his Ph.D. He is the author of more than 150 scientific publications and author or editor of eight books, including a textbook on conservation science. Kareiva is a fellow of the American Academy of Arts and Sciences and a member of The National Academy of Sciences. Before joining The Nature Conservancy, Kareiva was the director of conservation biology at the Northwest Fisheries Science Center, and before that he was a professor at University of Washington and Brown University, with teaching or faculty stints at Stanford University, University of Virginia, Uppsala University, and Oxford University. His current research concerns the connection between human activities and changes in ecosystem services, as part of the Natural Capital Project, which he co-founded with Gretchen Daily, Steve Polasky, and Taylor Ricketts. Kareiva also is studying the linkage between the sustainability initiatives of global corporations and their impact on ecosystems as well as their own corporate performance. In the past, Kareiva has published on biotechnology, agriculture, risk assessment, climate change, invasive species, and the importance of getting our children into nature. He currently lives in Seattle, WA. |
Abstract: Polls, presidential politics, and relentlessly increasing greenhouse gas emissions expose an environmental movement that is running on 20th Century metaphors in a 21st Century world. All of the land protection in the world will do little good if 7 billion people do not move to "green behavior." By dissecting past failures, we can learn where to go in the future with how we talk about and do conservation. We need to stop overstating doom and gloom, and recognize that opportunity, not despair, motivates people. Luckily, we have the science to support a new message of a resilient earth, which can then be a foundation for leaving behind worshipping at the false temple of pristine nature. |
|
|
|
|
Nicotinic Acetylcholine Receptor Function Modulates Impulsivity in ADHD: Clinical Implications |
Sunday, May 26, 2013 |
9:00 AM–9:50 AM |
Auditorium Room 1 (Convention Center) |
Area: EAB; Domain: Applied Research |
Instruction Level: Intermediate |
CE Instructor: Alexandra S Potter, Ph.D. |
Chair: Federico Sanabria (Arizona State University) |
ALEXANDRA S. POTTER (University of Vermont) |
Dr. Alexandra Potter is a research assistant professor and the associate director of the Clinical Neuroscience Research Unit at the University of Vermont. Dr. Potter received her Ph.D. in Clinical Psychology from the University of Vermont in 2003, and accepted a faculty position at the University of Vermont in 2004 after completing her clinical internship. She is a licensed clinical psychologist who maintains a small practice working with children and families with developmental disabilities in addition to her research. Her research program is focused on understanding the role of nicotinic acetylcholine receptor function in complex behaviors such as impulsive responding. She currently uses methodologies including acute pharmacological challenge and functional magnetic resonance imaging (fMRI) either alone or in combination to explore the underlying neurobiology of impulsivity in a variety of subject groups including adolescents and adults with ADHD, patients with Parkinson's disease, young adults with prodromal schizophrenia, and cigarette smokers. This basic approach uses well defined behavioral phenotypes (such as impulsive responding, or high risk taking) that can be precisely measured to understand their relationship with both clinical behaviors and cortical circuitry. |
Abstract: Background: Impulsivity is a central behavioral feature of attention deficit-hyperactivity disorder (ADHD) and many other psychiatric and substance use disorders. In recent years, the multi-dimensional nature of impulsivity has been recognized with cognitive processes including risk and reward evaluation, response inhibition, and delay discounting implicated in impulsive behavior. The nicotinic acetylcholine receptor (nAChR) system has long been recognized for its role in regulating attention. Understanding the role of nAChR function in impulsivity has widespread clinical implication including providing a novel pharmacological treatment target. Methods: Data from human experiments using pharmacological manipulations of nAChR function and measuring response inhibition, risk taking and delay discounting will be presented. Studies using acute pharmacological challenge in combination with fMRI will illustrate potential mechanisms for nAChR regulation of impulsivity. Results: Acute nicotine and novel nicotinic agonists improve response inhibition and delay aversion in ADHD. Nicotine and mecamylamine (a nicotinic antagonist) have rate dependent effects on risk taking regardless of diagnostic group. Both nicotine and a novel nicotinic agonist significantly decrease the cognitive and clinical symptoms of ADHD. Conclusion: Targeting nAChR function may provide a novel treatment target for ADHD and other disorders involving impulsive behavior. The use of reliable laboratory measures of different facets of impulsivity will allow for refined treatment strategies targeting precise cognitive mechanism related to impulsivity. |
Target Audience: Graduate students, practitioners, and scientists in psychology and mental health. |
Learning Objectives: 1. At the conclusion of this talk, participants will be able to identify different cognitive mechanisms that underlie impulsive behavior in ADHD. 2. At the conclusion of this talk, participants will be able to discuss how nicotinic acetylcholine receptor function affects impulsive behavior in normal development and psychiatric disorders. |
|
|
|
|
Using Facial and Postural Cues to Predict Future Behavior in Both Canids and Humans |
Sunday, May 26, 2013 |
11:00 AM–11:50 AM |
Ballroom B (Convention Center) |
Area: AAB; Domain: Service Delivery |
Instruction Level: Basic |
CE Instructor: Patricia McConnell, Ph.D. |
Chair: Megan E. Maxwell (Pet Behavior Change, LLC) |
PATRICIA MCCONNELL (University of Wisconsin-Madison) |
Patricia McConnell, Ph.D., is an ethologist and Certified Applied Animal Behaviorist, who has consulted with cat and dog lovers for more than 24 years. She combines a thorough understanding of the science of behavior with years of practical, applied experience. Her nationally syndicated radio show, Calling All Pets, played in more than 110 cities for 14 years and her television show, Petline, played on Animal Planet for two and a half years. She is a frequent contributor to The Bark magazine ("the New Yorker of Dog Magazines") and is an adjunct professor in zoology at the University of Wisconsin-Madison, teaching "The Biology and Philosophy of Human/Animal Relationships." Dr. McConnell speaks to training organizations, veterinary conferences, academic meetings and animal shelters around the world about dog and cat behavior, and on science-based and humane solutions to serious behavioral problems. She is the author of 14 books on training and behavioral problems, as well as the critically acclaimed books, The Other End of the Leash (translated into 14 languages), For the Love of a Dog, and Tales of Two Species. For more information, go to http://www.patriciamcconnell.com or visit her blog at www.theotherendoftheleash.com. |
Abstract: Both behavior analysts and ethologists are aware that observable changes in facial expressions and body postures provide invaluable information about behavior. This presentation will include slides and videos illustrating subtle changes in expression in humans and canids that are not only similar, but are often predictive of future behavior. This perspective is not new: Charles Darwin wrote an entire book, The Expression of the Emotions in Man and Animals, about the predictive value and comparative similarity of emotional expression in man and selected mammals. However, recent advances in visual analysis and neurobiology have greatly advanced our understanding of the link between expression, emotion, and future behavior. This information can be used by analysts working with either species, who are interested in improving their ability to notice, evaluate, and act on subtle but observable changes in facial expressions or body postures. |
Target Audience: Behavior analysts interested in improving their skill in interpreting facial expressions and body postures as predictors of future behavior and suggestions about internal emotional states. |
Learning Objectives: 1) At the conclusion of the event, participants will be able to identify the subtle but universal facial expressions related to primal emotions in mammals, such as fear, anger and joy, and use them to predict the probability of future behavior. 2) At the conclusion of the event, through videos testing their skills, participants will be better able to detect subtle micro-expressions in the expressions and movements of both people and domestic dogs. |
|
|
|
|
Experimental Mysticism, Psilocybin, and Quantum Behavior Change: Research Results and Treatment Implications |
Sunday, May 26, 2013 |
11:00 AM–11:50 AM |
Auditorium Room 1 (Convention Center) |
Area: BPH; Domain: Basic Research |
Instruction Level: Basic |
CE Instructor: Roland R Griffiths, Ph.D. |
Chair: Jonathan W. Pinkston (University of North Texas) |
ROLAND R. GRIFFITHS (Johns Hopkins University School of Medicine) |
Roland R. Griffiths, Ph.D., is a professor in the Departments of Psychiatry and Neurosciences at the Johns Hopkins University School of Medicine. His principal research focus in both clinical and preclinical laboratories has been on the behavioral pharmacology of mood-altering drugs. His research has been largely supported by grants from the National Institutes of Health, and he is the author of more than 300 journal articles and book chapters. He has been a consultant to the National Institutes of Health and to numerous pharmaceutical companies in the development of new psychotropic drugs. He is also a member of the Expert Advisory Panel on Drug Dependence for the World Health Organization. He has conducted extensive research with sedative-hypnotics and caffeine. About 12 years ago, he initiated a research program with the classic hallucinogen psilocybin, including studies of the effects of psilocybin in healthy volunteers and cancer patients, and a pilot study of psilocybin-facilitated smoking cessation. |
Abstract: Quantum behavioral change refers to sudden, distinctive, and benevolent experiences resulting in enduring changes in a broad range of emotions, cognitions and behaviors. Although the phenomenon of quantum change has been well described for more than 100 years, it has rarely been addressed within modern psychology and there are few meaningful prospective experimental studies because such experiences usually occur at low rates and often unpredictably. Recent rigorous double-blind studies at Johns Hopkins have shown that under carefully controlled conditions psilocybin, the active component of hallucinogenic mushrooms, can occasion profound personally and spiritually meaningful experiences (i.e., mystical-type or insightful-type experiences) in the majority of healthy participants. The experiences mediate sustained positive changes in behavior, attitudes, and personality. As assessed with questionnaires, most volunteers had a "complete" mystical-type experience after a high dose of psilocybin, although more than a third of volunteers also had experiences characterized by some fear, anxiety, or unpleasant psychological struggle. The finding that psilocybin can occasion, in most people studied, quantum change experiences indicates that such experiences and the behavioral changes they produce are now amenable to rigorous prospective scientific study. An exciting direction for future research is the exploration of possible therapeutic benefits of such experiences in treatment of various psychological and behavioral conditions (e.g., anxiety and depression among patients with life-threatening medical conditions such as cancer; treatment of behaviorally based public health problems such as drug dependence disorders). |
Target Audience: The target audience is researchers and practitioners interested in current therapeutic uses of hallucinogenic compounds, their behavioral pharmacology, and potential for widespread behavior change. |
Learning Objectives: 1. Learn about the pharmacology and history of psilocybin 2. Learn research demonstrating the abrupt and sustained changes in attitudes and behavior occasioned by psilocybin 3. Learn about possible therapeutic applications of psilocybin |
|
|
|
|
Context, Operant Behavior, and Extinction |
Sunday, May 26, 2013 |
2:00 PM–2:50 PM |
Main Auditorium (Convention Center) |
Area: SCI; Domain: Basic Research |
CE Instructor: Iser Guillermo DeLeon, Ph.D. |
Chair: Iser Guillermo DeLeon (Kennedy Krieger Institute) |
MARK E. BOUTON (University of Vermont) |
Mark E. Bouton received his B.A. from Williams College and his Ph.D. from the University of Washington. He is the Robert B. Lawson Green and Gold Professor of Psychology at the University of Vermont, where he has been teaching since 1980. Since that time, his research has investigated the relationships among context, behavior, and memory, with a special emphasis on inhibitory processes like extinction. His research has been funded by the National Science Foundation and the National Institutes of Health since 1981. Since at least 1988, he has been publishing translational papers that attempt to connect basic behavioral science (learning theory) with clinical issues such as relapse after therapy, panic disorder, fear and anxiety, and overeating and addiction. He has been a Fulbright Scholar, a James McKeen Cattell Scholar, a University Scholar at the University of Vermont, a Fellow at the Center for Advanced Study in the Behavioral Sciences (Stanford), and editor of the Journal of Experimental Psychology: Animal Behavior Processes (1998-2003). He is a fellow of the American Psychological Association, the American Psychological Society, and the Society of Experimental Psychologists, and in 2010 was awarded the Gantt Medal by the Pavlovian Society. He is currently writing the second edition of his 2007 textbook, Learning and behavior: A Contemporary Synthesis (Sinauer Associates). |
Abstract: Although extinction in Pavlovian learning is highly context-dependent, less research has investigated the role of context in the extinction of operant learning. This talk will fill this gap and explore a number of parallels between Pavlovian and operant extinction. Recent research has studied the "renewal" effect after operant extinction, in which extinguished responding returns when the context is changed. We have produced clear evidence of ABA, ABC, and AAB renewal (where the letters correspond to the contexts of conditioning, extinction, and testing, respectively), even when the learning history of the contexts is controlled. We also have demonstrated renewal in nondeprived rats working for sucrose or sweet/fatty food pellets--the rodent equivalent of junk food. The ABC and AAB renewal effects suggest that operant extinction is more context-dependent than operant conditioning. Other experiments have studied "resurgence," in which a behavior that is extinguished while a second is reinforced recovers when the second behavior is extinguished. Resurgence can be viewed as another renewal effect. Contextual cues have a general role in the control of operant behavior. But the extinction of operant behavior, like the extinction of respondent behavior, is especially sensitive to the context, with a number of interesting implications for understanding behavioral inhibition, lapse, and relapse. |
|
|
|
|
Mixing Rewards: The Effect of Drugs of Abuse on Sexual Behavior |
Sunday, May 26, 2013 |
3:00 PM–3:50 PM |
Main Auditorium (Convention Center) |
Area: EAB; Domain: Basic Research |
Instruction Level: Intermediate |
CE Instructor: Chana Akins, Ph.D. |
Chair: Matthew C. Bell (Santa Clara University) |
CHANA AKINS (University of Kentucky) |
Dr. Chana K. Akins is a professor of psychology at the University of Kentucky. She serves as a faculty member in the behavioral neuroscience and psychopharmacology area and is the current associate chair of the department. She received her Ph.D. in 1994 from the University of Texas, where she conducted research on learning and sexual behavior under the direction of Dr. Michael Domjan. Her current research involves investigating the effects of drugs of abuse on reward and sexual motivation. She has a unique avian model, Japanese quail. She has more than 40 publications and has published in journals such as Pharmacology, Biochemistry, and Behavior; Experimental & Clinical Psychopharmacology; Behavioural Pharmacology; and Physiology and Behavior. Dr. Akins has been the recipient of a Mentored Research Scientist Development Award (K01) from the National Institute on Drug Abuse (NIDA) to study drugs of abuse using an avian model. She currently has an R01 from NIDA to study the effects of cocaine on sexual motivation. She has served as secretary-treasurer for American Psychological Association's Division 6 (Behavioral Neuroscience & Comparative Psychology) and as awards chair for Division 28 (Psychopharmacology and Substance Abuse). She is currently the president of Division 6. |
Abstract: Evidence has been increasing that drugs of abuse alter sexual motivation, arousal, and performance. Drugs use also has been linked to an increase in high risk sexual behaviors such as increased sexual activity, multiple sex partners, and unprotected sex. This presentation will review the findings of the effect of drugs of abuse on sexual motivation and performance in humans and nonhuman animals, including those from a laboratory with an avian species. In particular, the effects of commonly abused drugs such as cocaine and methamphetamine will be discussed. The presentation also will include data on the effects of drugs of abuse on a risk-taking model recently developed in a laboratory. Finally, potential brain areas where drugs of abuse may be exerting their effect on sexual behavior will be discussed. |
Target Audience: Undergraduates, Graduate students, Post-docs, Faculty |
Learning Objectives: At the conclusion of the event, the participant will be able to 1) provide evidence for the influence of drugs of abuse on sexual behavior, and 2) describe the neural circuitry that may be activated by sex and drugs. |
|
|